Phenotype of BTK‐lacking myeloid cells during prolonged COVID‐19 and upon convalescent plasma

XLA patient with 7‐month course of COVID‐19 with persistent plasma SARS‐CoV‐2 load revealed a sustained non‐inflammatory profile of myeloid cells in association with contained severity of disease, arguing in favor of the use of BTK inhibitors in SARS‐COV‐2 infection.

Detalles Bibliográficos
Autores principales: Gomes, André M. C., Farias, Guilherme B., Trombetta, Amelia C., Godinho‐Santos, Ana, Parreira, Inês, Gonçalves, Hélder Diogo, Simões, Mariana Lessa, Aguiar, Patrício, Deveza, Maria Manuel, Inácio, João, Sousa, Ana E., da Silva, Susana Lopes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874515/
https://www.ncbi.nlm.nih.gov/pubmed/36208028
http://dx.doi.org/10.1111/ejh.13881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874515/
https://www.ncbi.nlm.nih.gov/pubmed/36208028
http://dx.doi.org/10.1111/ejh.13881

Ejemplares similares